Dr. Albanyan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4100 John R St
HW4HO
Detroit, MI 48201Phone+1 313-576-8740Fax+1 313-576-8381
Education & Training
- King Saud University College of MedicineClass of 2011
Certifications & Licensure
- FL State Medical License 2021 - 2023
- MI State Medical License 2015 - 2019
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 18 citationsSevere hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion.Kai Rejeski, Ariel Perez, Gloria Iacoboni, Viktoria Blumenberg, Veit L Bücklein
Science Advances. 2023-09-22 - 17 citationsThe CAR-HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene aut...Kai Rejeski, Yucai Wang, Omar Albanyan, Javier Munoz, Pierre Sesques
American Journal of Hematology. 2023-11-01 - 6 citationsInferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemi...Veit Bücklein, Ariel Perez, Kai Rejeski, Gloria Iacoboni, Vindi Jurinovic
Hemasphere. 2023-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: